Showing results (61-70 of 229) with videos related to

Sort By:
Pageof 23
Pharmacogenomics|October 23, 2018
Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT*3 allelesDunja Urbančič, Alenka Šmid, Gabriele Stocco, et al.
Clinical Pharmacology and Therapeutics|September 5, 2025
Unraveling Novel Genetic Determinants of Thiopurine Response Via TWASCarlotta Bidoli, Wenjian Yang, Seth E Karol, et al.
Anticancer Research|February 6, 2009
ABCB1 gene polymorphisms and expression of P-glycoprotein and long-term prognosis in colorectal cancerSara De Iudicibus, Alessandro De Pellegrin, Gabriele Stocco, et al.
Pediatric Blood & Cancer|July 22, 2009
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid responseSara Marino, Federico Verzegnassi, Paolo Tamaro, et al.
Clinical and Translational Science|November 2, 2019
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric PatientsMarianna Lucafò, Martina Franzin, Cristina Lagatolla, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 23, 2018
Pharmacogenetics of treatments for inflammatory bowel diseaseMarianna Lucafò, Raffaella Franca, Davide Selvestrel, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Pharmacogenetics of thiopurinesRaffaella Franca, Giulia Zudeh, Sofia Pagarin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2022
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel diseaseDavide Selvestrel, Gabriele Stocco, Marina Aloi, et al.
Clinical Pharmacology and Therapeutics|December 14, 2021
Machine Learning Application in a Phase I Clinical Trial Allows for the Identification of Clinical-Biomolecular Markers Significantly Associated With ToxicityLuca Bedon, Erika Cecchin, Emanuele Fabbiani, et al.
Clinical Chemistry and Laboratory Medicine|March 3, 2010
Decision criteria for rational selection of homogeneous genotyping platforms for pharmacogenomics testing in clinical diagnosticsRaffaele Di Francia, Ferdinando Frigeri, Massimiliano Berretta, et al.
Pageof 23